v3.26.3
SCHEDULE OF OTHER RECEIVABLE (Details) (Parenthetical) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Aggregate principal amount $ 499,688  
Interest rate 9.00%  
Borrowings $ 195,182  
Proceeds from sale of subsidiary [1] 2,416,086
Parent Company [Member]    
Aggregate principal amount $ 14,160,101  
[1] There was $2,416,086 receivable from the sale of the Company’s subsidiary, SYCI, which is due in 2026 from Shandong Rongyuan Pharmaceutical Co., Ltd.